Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
75.6M
-
Number of holders
-
135
-
Total 13F shares, excl. options
-
55.3M
-
Shares change
-
+5.83M
-
Total reported value, excl. options
-
$1.36B
-
Value change
-
+$58.4M
-
Put/Call ratio
-
1.03
-
Number of buys
-
86
-
Number of sells
-
-55
-
Price
-
$24.62
Significant Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (SWTX) as of Q2 2022
177 filings reported holding SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q2 2022.
SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (SWTX) has 135 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55.3M shares
of 75.6M outstanding shares and own 73.09% of the company stock.
Largest 10 shareholders include FMR LLC (7.41M shares), ORBIMED ADVISORS LLC (6.03M shares), Bain Capital Life Sciences Investors, LLC (4.83M shares), STATE STREET CORP (3.89M shares), PERCEPTIVE ADVISORS LLC (3.87M shares), ArrowMark Colorado Holdings LLC (3.3M shares), VANGUARD GROUP INC (2.74M shares), BlackRock Inc. (2.62M shares), BOXER CAPITAL, LLC (2.08M shares), and BANK OF AMERICA CORP /DE/ (1.65M shares).
This table shows the top 135 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.